atorvastatin has been researched along with butylhydroxybutylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figueiredo, A; Mota, A; Neto, P; Parada, B; Pinto, Â; Reis, F; Rocha-Pereira, P; Sereno, J; Teixeira, F; Xavier-Cunha, M | 1 |
| Al-Tantawy, SM; El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG | 1 |
2 other study(ies) available for atorvastatin and butylhydroxybutylnitrosamine
| Article | Year |
|---|---|
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Atorvastatin; Biomarkers, Tumor; Butylhydroxybutylnitrosamine; Cell Proliferation; Drug Evaluation, Preclinical; Heptanoic Acids; Male; Oxidative Stress; Pyrroles; Rats, Wistar; Urinary Bladder; Urinary Bladder Neoplasms | 2012 |
Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
Topics: Animals; Apoptosis; Atorvastatin; Butylhydroxybutylnitrosamine; Cell Proliferation; Docosahexaenoic Acids; Eicosapentaenoic Acid; Male; Oxidative Stress; Random Allocation; Rats; Urinary Bladder Neoplasms | 2017 |